These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 16156950
1. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy. Di Paolo N, Gaggiotti E, Galli F. Redox Rep; 2005; 10(3):121-30. PubMed ID: 16156950 [Abstract] [Full Text] [Related]
2. Extracorporeal blood oxygenation and ozonation (EBOO) in man. preliminary report. Di Paolo N, Bocci V, Garosi G, Borrelli E, Bravi A, Bruci A, Aldinucci C, Capotondo L. Int J Artif Organs; 2000 Feb; 23(2):131-41. PubMed ID: 10741810 [Abstract] [Full Text] [Related]
3. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. Di Paolo N, Bocci V, Salvo DP, Palasciano G, Biagioli M, Meini S, Galli F, Ciari I, Maccari F, Cappelletti F, Di Paolo M, Gaggiotti E. Int J Artif Organs; 2005 Oct; 28(10):1039-50. PubMed ID: 16288443 [Abstract] [Full Text] [Related]
4. Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO). Di Paolo N, Bocci V, Cappelletti F, Petrini G, Gaggiotti E. Int J Artif Organs; 2002 Dec; 25(12):1194-8. PubMed ID: 12518965 [Abstract] [Full Text] [Related]
5. Rational bases for using oxygen-ozonetherapy as a biological response modifier in sickle cell anemia and beta-thalassemia: a therapeutic perspective. Bocci V, Aldinucci C. J Biol Regul Homeost Agents; 2004 Dec; 18(1):38-44. PubMed ID: 15323359 [Abstract] [Full Text] [Related]
6. Combination of LC-MS- and GC-MS-based metabolomics to study the effect of ozonated autohemotherapy on human blood. Ciborowski M, Lipska A, Godzien J, Ferrarini A, Korsak J, Radziwon P, Tomasiak M, Barbas C. J Proteome Res; 2012 Dec 07; 11(12):6231-41. PubMed ID: 23148940 [Abstract] [Full Text] [Related]
7. Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device. Bocci V, Zanardi I, Travagli V, Di Paolo N. Artif Organs; 2007 Sep 07; 31(9):743-8. PubMed ID: 17725702 [Abstract] [Full Text] [Related]
8. Can the combination of localized "proliferative therapy" with "minor ozonated autohemotherapy" restore the natural healing process? Gracer RI, Bocci V. Med Hypotheses; 2005 Sep 07; 65(4):752-9. PubMed ID: 15951134 [Abstract] [Full Text] [Related]
9. Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy. Biedunkiewicz B, Tylicki L, Rachon D, Hak L, Nieweglowski T, Chamienia A, Debska-Slizien A, Mysliwska J, Rutkowski B. Int J Artif Organs; 2004 Sep 07; 27(9):766-71. PubMed ID: 15521216 [Abstract] [Full Text] [Related]
10. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Martínez-Sánchez G, Delgado-Roche L, Díaz-Batista A, Pérez-Davison G, Re L. Eur J Pharmacol; 2012 Sep 15; 691(1-3):156-62. PubMed ID: 22796450 [Abstract] [Full Text] [Related]
11. To what extent does ozone therapy need a real biochemical control system? Assessment and importance of oxidative stress. Hernández FA. Arch Med Res; 2007 Jul 15; 38(5):571-8. PubMed ID: 17560465 [Abstract] [Full Text] [Related]
12. Ozone therapy effects on biomarkers and lung function in asthma. Hernández Rosales FA, Calunga Fernández JL, Turrent Figueras J, Menéndez Cepero S, Montenegro Perdomo A. Arch Med Res; 2005 Jul 15; 36(5):549-54. PubMed ID: 16099337 [Abstract] [Full Text] [Related]
13. Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium. Tylicki L, Biedunkiewicz B, Nieweglowski T, Chamienia A, Slizien AD, Luty J, Lysiak-Szydlowska W, Rutkowski B. Artif Organs; 2004 Feb 15; 28(2):234-7. PubMed ID: 14961966 [Abstract] [Full Text] [Related]
14. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Shinriki N, Suzuki T, Takama K, Fukunaga K, Ohgiya S, Kubota K, Miura T. Haematologia (Budap); 1998 Feb 15; 29(3):229-39. PubMed ID: 10069448 [Abstract] [Full Text] [Related]
15. Ozone oxidative post-conditioning in acute renal failure. Calunga JL, Trujillo Y, Menéndez S, Zamora Z, Alonso Y, Merino N, Montero T. J Pharm Pharmacol; 2009 Feb 15; 61(2):221-7. PubMed ID: 19178770 [Abstract] [Full Text] [Related]
16. No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients. Tylicki L, Biedunkiewicz B, Rachon D, Nieweglowski T, Hak L, Chamienia A, Debska-Slizien A, Aleksandrowicz E, Mysliwska J, Rutkowski B. Mediators Inflamm; 2004 Dec 15; 13(5-6):377-80. PubMed ID: 15770057 [Abstract] [Full Text] [Related]
17. Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients. Tylicki L, Biedunkiewicz B, Nieweglowski T, Grabowska M, Chamienia A, Slizien AD, Rutkowski B. Artif Organs; 2004 May 15; 28(5):513-7. PubMed ID: 15156869 [Abstract] [Full Text] [Related]
18. Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients. Molinari F, Simonetti V, Franzini M, Pandolfi S, Vaiano F, Valdenassi L, Liboni W. Int J Immunopathol Pharmacol; 2014 May 15; 27(3):379-89. PubMed ID: 25280029 [Abstract] [Full Text] [Related]
19. Effects of ozone on isolated peripheral blood mononuclear cells. Larini A, Bocci V. Toxicol In Vitro; 2005 Feb 15; 19(1):55-61. PubMed ID: 15582356 [Abstract] [Full Text] [Related]